A Phase 2/3 interventional study of Fistula Pouching System in Cutaneous Fistula, sponsored by Coloplast A/S. Completed at 7 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-02-01.
Sponsored by Coloplast A/S · Phase 2/3, Interventional, and Treatment
The purpose of this investigation is to carry out a clinical evaluation of a newly developed fistula pouching system's ability to function as a good pouch for fistulas, with the opening on the skin of the stomach or in a wound on the skin of the stomach.
731 studies on the registry are indexed under Fistula; 103 are open to participants now.
This study's enrollment of 22 is below the median of 60 across 484 interventional studies indexed under Fistula.
Browse Fistula studies →Coloplast A/S is the lead sponsor of 146 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
3 different sizes of fistula pounching system
Also known as: Fistula and Wound Management System
Nurse's preference to use the test product in the future
Time frame: Up to 18 days
This study is completed, as verified in Jan 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cutaneous Fistula
Coloplast A/S